Nanoparticle probe technology typically yields results from which sample type and in approximately how long?

• A. Blood; 2.5 hours
• B. Blood; 1 hour
• C. CSF; 2 hours
• D. Urine; 4 hours

Answer: (A)

Nanoparticle probe technology relies on nanoparticles bound to specific probes that recognize a target biomarker in a clinical sample. The sample type needs to provide enough of that target and a compatible matrix for reliable binding and signal readout. Blood (plasma or serum) is the most common choice because circulating biomarkers are readily detectable there, and the matrix supports consistent interaction with the probes plus straightforward processing in the lab. The workflow—collecting the sample, incubating with the nanoparticle probes, washing away nonspecific material, and reading the signal—takes time, typically a few hours rather than minutes or days. In many centralized or rapid-diagnostic setups, about 2.5 hours is a realistic turnaround for obtaining a result with this approach. While other fluids like CSF or urine can be used for specialized tests, blood and the approximately 2.5-hour timeframe best reflect the typical use and performance of nanoparticle probe diagnostics in routine settings.